Experimental infection of ponies with equine influenza A2 (H3N8) virus strains of different pathogenicity elicits varying interferon and interleukin-6 responses.

The production of interferon (IFN), interleukin-6 (IL-6), and tumor necrosis factor (TNF) was monitored in horses during the course of influenza A2 virus infections. The effects of two virus strains, Newmarket/2/93 and Sussex/89, were compared, of which the latter is considered the more pathogenic in terms of clinical signs. Ten naive ponies were infected with influenza A/equine/Sussex/89 and 10 with influenza A/equine/Newmarket/2/93, respectively. As expected ponies infected with Sussex/89 showed the most pronounced clinical signs but there was no notable difference in viral excretion compared with Newmarket/2/93. IFN was detected in nasal secretions of all ponies infected with Sussex/89 but only in 2 ponies infected with Newmarktet/2/93. IFN was not detected in serum of any animal. IL-6 activity was detected in nasal secretions of all experimental animals from day 2 and onwards, but showed markedly higher IL-6 responses were observed in ponies infected with Sussex/89. No TNF activity was detected in any of the samples collected. In summary, equine influenza A 2 infections elicited local, and in some cases systemic, IFN and IL-6 responses in the ponies. Interestingly, there was some evidence that the duration and levels of cytokine responses may be related to the pathogenicity of the influenza strains.

[1]  L. Moldawer,et al.  Endotoxin-induced production of interleukin 6 by equine peritoneal macrophages in vitro. , 1992, American journal of veterinary research.

[2]  J. A. Majde Viral double-stranded RNA, cytokines, and the flu. , 2000, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[3]  D. Hannant,et al.  Antibody isotype responses in the serum and respiratory tract to primary and secondary infections with equine influenza virus (H3N8). , 1989, Veterinary microbiology.

[4]  M. Kluger,et al.  Cytokines and the acute phase response to influenza virus in mice. , 1995, The American journal of physiology.

[5]  T. Linné,et al.  Evolution of H3N8 equine influenza virus from 1963 to 1991. , 1994, Virus research.

[6]  W. Doyle,et al.  Effect of experimental influenza A infection on systemic immune and inflammatory parameters in allergic and nonallergic adult subjects. , 2001, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[7]  P. Lansdorp,et al.  Production of hybridoma growth factor by human monocytes , 1987, European journal of immunology.

[8]  D. Hannant,et al.  Duration of circulating antibody and immunity following infection with equine influenza virus , 1988, Veterinary Record.

[9]  Amer A. Beg,et al.  Influenza A Virus NS1 Protein Prevents Activation of NF-κB and Induction of Alpha/Beta Interferon , 2000, Journal of Virology.

[10]  K. Reeth Cytokines in the pathogenesis of influenza. , 2000 .

[11]  C. Hultén,et al.  The Acute Phase Protein Serum Amyloid A (SAA) as an Inflammatory Marker in Equine Influenza Virus Infection , 1999, Acta Veterinaria Scandinavica.

[12]  H. Duncan,et al.  Equine immunity to viruses. , 2000 .

[13]  T. Pritts,et al.  Mucosal and enterocyte IL-6 production during sepsis and endotoxemia--role of transcription factors and regulation by the stress response. , 2002, American journal of surgery.

[14]  H. Nauwynck,et al.  Differential production of proinflammatory cytokines in the pig lung during different respiratory virus infections: correlations with pathogenicity , 1999, Research in Veterinary Science.

[15]  J. Mumford,et al.  Experimental infection of ponies with equine influenza (H3N8) viruses by intranasal inoculation or exposure to aerosols. , 1990, Equine veterinary journal.

[16]  F. Belardelli,et al.  The neglected role of type I interferon in the T-cell response: implications for its clinical use. , 1996, Immunology today.

[17]  A. García-Sastre,et al.  Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses. , 2001, Virology.

[18]  D. Gemsa,et al.  Defense against influenza A virus infection: essential role of the chemokine system. , 2001, Immunobiology.

[19]  G. Franchini,et al.  Targeting the mucosa: genetically engineered vaccines and mucosal immune responses , 2000, Genes and Immunity.

[20]  C. Dinarello Cytokines as endogenous pyrogens. , 1999, The Journal of infectious diseases.

[21]  A. García-Sastre,et al.  Activation of Interferon Regulatory Factor 3 Is Inhibited by the Influenza A Virus NS1 Protein , 2000, Journal of Virology.

[22]  J. Mumford,et al.  WHO/OIE meeting: consultation on newly emerging strains of equine influenza. 18-19 May 1992, Animal Health Trust, Newmarket, Suffolk, UK. , 1993, Vaccine.

[23]  J. Mcghee,et al.  Role of interleukin-6 in human and mouse mucosal IgA plasma cell responses , 1991, Immunologic research.

[24]  R. MacKay,et al.  Tumor necrosis factor activity in the circulation of horses given endotoxin. , 1991, American journal of veterinary research.

[25]  S. De Clercq,et al.  Efficacy of vaccination of pigs with different H1N1 swine influenza viruses using a recent challenge strain and different parameters of protection. , 2001, Vaccine.

[26]  K. Melén,et al.  Inflammatory responses in influenza A virus infection. , 2000, Vaccine.

[27]  S. Romagnani,et al.  Understanding the role of Th1/Th2 cells in infection. , 1996, Trends in microbiology.

[28]  A. Husband,et al.  Analysis of the mucosal microenvironment: factors determining successful responses to mucosal vaccines. , 1999, Veterinary immunology and immunopathology.

[29]  R. Webster,et al.  Influence of host species on the evolution of the nonstructural (NS) gene of influenza A viruses. , 1998, Virus research.

[30]  F. Hayden,et al.  Symptom pathogenesis during acute influenza: Interleukin‐6 and Other cytokine responses , 2001, Journal of medical virology.

[31]  J. Lord,et al.  IFN-α and IFN-β: a link between immune memory and chronic inflammation , 2000 .

[32]  F. Belardelli Role of interferons and other cytokines in the regulation of the immune response , 1995, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[33]  C. Bogdan The function of type I interferons in antimicrobial immunity. , 2000, Current opinion in immunology.

[34]  D. Hannant,et al.  Cell mediated immune responses in ponies following infection with equine influenza virus (H3N8): the influence of induction culture conditions on the properties of cytotoxic effector cells. , 1989, Veterinary immunology and immunopathology.

[35]  T. Linné,et al.  Identification of two antigenically and genetically distinct lineages of H3N8 equine influenza virus in Sweden , 1998, Epidemiology and Infection.

[36]  R. Webster,et al.  Seroepidemiological and molecular evidence for the presence of two H3N8 equine influenza viruses in China in 1993-94. , 1995, The Journal of general virology.

[37]  F. Hayden,et al.  Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense. , 1998, The Journal of clinical investigation.

[38]  S. Paludan,et al.  Molecular Pathways in Virus-Induced Cytokine Production , 2001, Microbiology and Molecular Biology Reviews.

[39]  C. Fossum,et al.  Temporary Suppression of Cell-Mediated Immunity in Standardbred Horses with Decreased Athletic Capacity , 1998, Acta Veterinaria Scandinavica.

[40]  W. Doyle,et al.  Evidence for cytokine mediation of disease expression in adults experimentally infected with influenza A virus. , 1999, The Journal of infectious diseases.

[41]  L. Oxburgh,et al.  Cocirculation of Two Distinct Lineages of Equine Influenza Virus Subtype H3N8 , 1999, Journal of Clinical Microbiology.

[42]  J. Mumford The equine influenza surveillance program. , 1999, Advances in Veterinary Medicine.

[43]  F. Hayden,et al.  Increased Interleukin-6 Levels in Nasal Lavage Samples following Experimental Influenza A Virus Infection , 1998, Clinical Diagnostic Laboratory Immunology.

[44]  K. Melén,et al.  Survey Molecular pathogenesis of influenza A virus infection and virus-induced regulation of cytokine gene expression , 1998 .

[45]  M. Studdert Virus infections of equines. , 1996 .

[46]  F. Belardelli,et al.  Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. , 2001, Immunity.

[47]  H. Nauwynck,et al.  Bronchoalveolar Interferon-α, Tumor Necrosis Factor-α, Interleukin-1, and Inflammation during Acute Influenza in Pigs: A Possible Model for Humans? , 1998, The Journal of infectious diseases.

[48]  G. Schild,et al.  Studies with inactivated equine influenza vaccine: 2. Protection against experimental infection with influenza virus A/equine/Newmarket/79 (H3N8) , 1983, Journal of Hygiene.

[49]  W G Alvord,et al.  Nasal cytokine and chemokine responses in experimental influenza A virus infection: results of a placebo-controlled trial of intravenous zanamivir treatment. , 1999, The Journal of infectious diseases.

[50]  J. Mumford,et al.  Studies with inactivated equine influenza vaccine: 1. Serological responses of ponies to graded doses of vaccine , 1983, Journal of Hygiene.